Financial information

The information source is the annual report of the company with business id 556718-9781

* Closing information (×1000) SEK

Fiscal year 202412 202312
Number of months: 12 12
Turnover: 1,002,613 Revenue Up 948,637 Revenue Up
Financial expenses: 7,029 Revenue Down 8,469 Revenue Up
Earnings before taxes: 330,165 Revenue Up 287,531 Revenue Up
Total assets: 1,211,124 Revenue Up 1,017,471 Revenue Up
Current assets: 1,024,229 Revenue Up 744,003 Revenue Up
Current liabilities: 211,348 Revenue Down 227,609 Revenue Up
Equity capital: 940,882 Revenue Up 730,968 Revenue Up
Share capital: 100 100
Number of employees: 28 Revenue Down 29 Revenue Up

Financial ratios

Solvency: 77.7% Revenue Up 71.8% Revenue Up
Turnover per employee: 35,808 Revenue Up 32,712 Revenue Up
Profitability: 32.9% Revenue Up 30.3% Revenue Down
Return on equity (ROE): 35.1% Revenue Down 39.3% Revenue Down
Current ratio: 484.6% Revenue Up 326.9% Revenue Up
Return on assets (ROA): 27.8% Revenue Down 29.1% Revenue Up

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202412
Number of months: 12
Turnover: 1,002,613
Financial expenses: 7,029
Earnings before taxes: 330,165
Total assets: 1,211,124
Current assets: 1,024,229
Current liabilities: 211,348
Equity capital: 940,882
Share capital: 100
Number of employees: 28

Financial ratios

Solvency: 77.7%
Turnover per employee: 35,808
Profitability: 32.9%
Return on equity (ROE): 35.1%
Current ratio: 484.6%
Return on assets (ROA): 27.8%